HIV/AIDS Therapy
Novel DNA enzymes can protect cells from HIV infection
Published in AIDS Weekly, August 4th, 2003
"Nucleic acid-based antiviral approaches have been tried against multiple HIV-1 genes with the purpose of downregulating its replication," researchers in India explained. "A unique stem-loop structure called TAR is present at the 5'-end of all HIV-1 transcripts; Tat and other cellular proteins bind to TAR and thus govern transcription."
"Therefore, HIV-1 TAR is an attractive target against which various antiviral approaches could be tried," according to S. Chakraborti and colleagues at the National Institute of Immunology in New Delhi, who "screened several DNA enzymes (Dz's)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-08-04)
More Articles from AIDS Weekly
- AIDS and HIV
Novel adenovirus-based SIV vaccine effective in macaques - HIV/AIDS Vaccine
Interferon resistance gene needed for modified vaccinia virus Ankara replication - HIV/AIDS Endocrinology
Immunologic response to psychological stress altered in HIV patients - HIV/AIDS Gene Therapy
Novel vectors may aid treatment of HIV-related brain damage - HIV/AIDS Therapy
Aspirin-like agent suppresses HIV replication - AIDS Epidemiology
60 Million Africans affected, says UNAIDS executive director - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
